{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:15Z","timestamp":1786985235564,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112281","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T05:46:19Z","timestamp":1633499179000},"page":"112281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation"],"prefix":"10.1016","volume":"144","author":[{"given":"Han","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"El-Ashram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.112281_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.biopha.2021.112281_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00436-014-4225-x","article-title":"Research and control of advanced schistosomiasis japonica in China","volume":"114","author":"Wu","year":"2015","journal-title":"Parasitol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2021.112281_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pt.2018.02.005","article-title":"Schistosome-induced fibrotic disease: the role of hepatic stellate cells","volume":"34","author":"Carson","year":"2018","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112281_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2021.112281_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.14423\/SMJ.0000000000000655","article-title":"Pirfenidone and nintedanib for treatment of idiopathic pulmonary fibrosis","volume":"110","author":"Sathiyamoorthy","year":"2017","journal-title":"South Med. J."},{"issue":"7","key":"10.1016\/j.biopha.2021.112281_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrc3256","article-title":"BET domain co-regulators in obesity, inflammation and cancer","volume":"12","author":"Belkina","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2021.112281_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.112281_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.12.005","article-title":"Bromodomains: structure, function and pharmacology of inhibition","volume":"106","author":"Ferri","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"51","key":"10.1016\/j.biopha.2021.112281_bib9","doi-asserted-by":"crossref","first-page":"15713","DOI":"10.1073\/pnas.1522163112","article-title":"BRD4 is a novel therapeutic target for liver fibrosis","volume":"112","author":"Ding","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2021.112281_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajpath.2013.04.020","article-title":"Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis","volume":"183","author":"Tang","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"14","key":"10.1016\/j.biopha.2021.112281_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137127","article-title":"Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice","volume":"5","author":"Sanders","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2021.112281_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570524","article-title":"The differential and dynamic progression of hepatic inflammation and immune responses during liver fibrosis induced by Schistosoma japonicum or carbon tetrachloride in mice","volume":"11","author":"Song","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2021.112281_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fmicb.2019.00066","article-title":"\u03b2-Actin: not a suitable internal control of hepatic fibrosis caused by Schistosoma japonicum","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2021.112281_bib14","doi-asserted-by":"crossref","first-page":"d808","DOI":"10.2741\/reeves","article-title":"Activation of hepatic stellate cells--a key issue in liver fibrosis","volume":"7","author":"Reeves","year":"2002","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.biopha.2021.112281_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2001\/870205","article-title":"Liver fibrosis and altered matrix synthesis","volume":"15","author":"Neubauer","year":"2001","journal-title":"Can. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112281_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11596-016-1594-7","article-title":"Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway","volume":"36","author":"Li","year":"2016","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.112281_bib17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.biopha.2021.112281_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/1178635317747281","article-title":"Some lipid droplets are more equal than others: different metabolic lipid droplet pools in hepatic stellate cells","volume":"10","author":"Molenaar","year":"2017","journal-title":"Lipid Insights"},{"issue":"12","key":"10.1016\/j.biopha.2021.112281_bib19","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112281_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jhep.2006.07.027","article-title":"Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells","volume":"46","author":"Cao","year":"2007","journal-title":"J. Hepatol."},{"issue":"40","key":"10.1016\/j.biopha.2021.112281_bib21","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.3748\/wjg.v16.i40.5047","article-title":"Daily genetic profiling indicates JAK\/STAT signaling promotes early hepatic stellate cell transdifferentiation","volume":"116","author":"Lakner","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.112281_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153055","article-title":"Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling","volume":"63","author":"Cao","year":"2019","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.biopha.2021.112281_bib23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41401-018-0194-4","article-title":"Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2\/STAT3 pathway and TGF-\u03b21\/Smad signaling","volume":"40","author":"Yang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2021.112281_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2018.11.018","article-title":"Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis","volume":"134","author":"Hassan","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:29:01Z","timestamp":1760099341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221010659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":24,"alternative-id":["S0753332221010659"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112281","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.04.235812","asserted-by":"object"}]},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112281"}}